Agency Information Collection Activities; Proposed Collection; Comment Request; Infant Formula Requirements, 52927-52933 [2017-24688]
Download as PDF
Federal Register / Vol. 82, No. 219 / Wednesday, November 15, 2017 / Notices
FEDERAL RESERVE SYSTEM
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
Food and Drug Administration
sradovich on DSK3GMQ082PROD with NOTICES
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The applications listed below, as well
as other related filings required by the
Board, are available for immediate
inspection at the Federal Reserve Bank
indicated. The applications will also be
available for inspection at the offices of
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the BHC Act (12 U.S.C. 1842(c)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than December 11,
2017.
A. Federal Reserve Bank of San
Francisco (Gerald C. Tsai, Director,
Applications and Enforcement) 101
Market Street, San Francisco, California
94105–1579:
1. CBC Bancorp; to become a bank
holding company by acquiring 98.3
percent of the voting shares of NCAL
Bancorp, and thereby indirectly acquire
Commercial Bank of California, all of
Irvine, California.
Board of Governors of the Federal Reserve
System, November 8, 2017.
Yao-Chin Chao,
Assistant Secretary of the Board.
[FR Doc. 2017–24653 Filed 11–14–17; 8:45 am]
BILLING CODE P
VerDate Sep<11>2014
19:58 Nov 14, 2017
Jkt 244001
[Docket No. FDA–2013–N–0545]
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Infant Formula
Requirements
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA or we) is
announcing an opportunity for public
comment on the proposed collection of
certain information by the Agency.
Under the Paperwork Reduction Act of
1995 (PRA), Federal Agencies are
required to publish notice in the
Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information, and
to allow 60 days for public comment in
response to the notice. This notice
invites comments on the information
collection provisions of our infant
formula regulations, including infant
formula labeling, quality control
procedures, notification requirements,
and recordkeeping. The notice also
invites comment on a pilot electronic
form that allows manufacturers of infant
formula to submit reports and
notifications in a standardized format.
DATES: Submit either electronic or
written comments on the collection of
information by January 16, 2018.
ADDRESSES: You may submit comments
as follows. Please note that late,
untimely filed comments will not be
considered. Electronic comments must
be submitted on or before January 16,
2018. The https://www.regulations.gov
electronic filing system will accept
comments until midnight Eastern Time
at the end of January 16, 2018.
Comments received by mail/hand
delivery/courier (for written/paper
submissions) will be considered timely
if they are postmarked or the delivery
service acceptance receipt is on or
before that date.
SUMMARY:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
52927
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2013–N–0545 for ‘‘Agency Information
Collection Activities; Proposed
Collection; Comment Request; Infant
Formula Requirements.’’ Received
comments, those filed in a timely
manner (see ADDRESSES), will be placed
in the docket and, except for those
submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
Dockets Management Staff between 9
a.m. and 4 p.m., Monday through
Friday.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
Agency will review this copy, including
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
E:\FR\FM\15NON1.SGM
15NON1
52928
Federal Register / Vol. 82, No. 219 / Wednesday, November 15, 2017 / Notices
https://www.regulations.gov. Submit
both copies to the Dockets Management
Staff. If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
‘‘confidential.’’ Any information marked
as ‘‘confidential’’ will not be disclosed
except in accordance with 21 CFR 10.20
and other applicable disclosure law. For
more information about FDA’s posting
of comments to public dockets, see 80
FR 56469, September 18, 2015, or access
the information at: https://www.gpo.gov/
fdsys/pkg/FR-2015-09-18/pdf/201523389.pdf.
Docket: For access to the docket to
read background documents or the
electronic and written/paper comments
received, go to https://
www.regulations.gov and insert the
docket number, found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Dockets Management
Staff, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT: Ila
S. Mizrachi, Office of Operations, Food
and Drug Administration, Three White
Flint North, 10A–12M, 11601
Landsdown St., North Bethesda, MD
20852, 301–796–7726, PRAStaff@
fda.hhs.gov.
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44
U.S.C. 3506(c)(2)(A)) requires Federal
Agencies to provide a 60-day notice in
the Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information,
before submitting the collection to OMB
for approval. To comply with this
requirement, FDA is publishing notice
of the proposed collection of
information set forth in this document.
With respect to the following
collection of information, we invite
comments on these topics: (1) Whether
the proposed collection of information
is necessary for the proper performance
of FDA’s functions, including whether
the information will have practical
utility; (2) the accuracy of FDA’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques,
when appropriate, and other forms of
information technology.
Under the
PRA (44 U.S.C. 3501–3520), Federal
Agencies must obtain approval from the
Office of Management and Budget
(OMB) for each collection of
information they conduct or sponsor.
‘‘Collection of information’’ is defined
in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests
or requirements that members of the
OMB Control Number 0910–0256—
Extension
Statutory requirements for infant
formula under the Federal Food, Drug,
and Cosmetic Act (the FD&C Act) are
intended to protect the health of infants
and include a number of reporting and
recordkeeping requirements. Among
other things, section 412 of the FD&C
Act (21 U.S.C. 350a) requires
SUPPLEMENTARY INFORMATION:
Infant Formula Requirements—21 CFR
parts 106 and 107
manufacturers of infant formula to
establish and adhere to quality control
procedures, notify us when a batch of
infant formula that has left the
manufacturers’ control may be
adulterated or misbranded, and keep
records of distribution. We have issued
regulations to implement the FD&C
Act’s requirements for infant formula in
parts 106 and 107 (21 CFR parts 106 and
107). We also regulate the labeling of
infant formula under the authority of
section 403 of the FD&C Act (21 U.S.C.
343). Under our labeling regulations for
infant formula in part 107, the label of
an infant formula must include nutrient
information and directions for use. The
purpose of these labeling requirements
is to ensure that consumers have the
information they need to prepare and
use infant formula appropriately.
We have developed an electronic form
(Form FDA 3978) that infant formula
manufacturers will be able to use to
electronically submit reports and
notifications in a standardized format to
FDA. Manufacturers that prefer to
submit paper submissions in a format of
their own choosing will still have the
option to do so, however. Form FDA
3978 prompts a respondent to include
reports and notifications in a standard
electronic format and helps the
respondent organize their submission to
include only the information needed for
our review. Draft screenshots of Form
FDA 3978 and instructions are available
for comment at https://www.fda.gov/
Food/GuidanceRegulation/FoodFacility
Registration/InfantFormula/default.htm.
Description of Respondents:
Respondents to this information
collection are manufacturers of infant
formula.
We estimate the burden of this
collection of information as follows:
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1
FD&C Act or 21 CFR section
1 ...........
2 ...........
3 ...........
7 ...........
Reports; Section 412(d) of the FD&C Act ...........
Notifications; § 106.120(b) ...................................
Reports
for
Exempt
Infant
Formula;
§ 107.50(b)(3) and (4).
Notifications
for
Exempt
Infant
Formula;§ 107.50(e)(2).
Requirements for Quality Factors Growth Monitoring Study Exemption; § 106.96(c).
Requirements for Quality Factors—PER Exemption; § 106.96(g).
New Infant Formula Registration; § 106.110 .......
8 ...........
Average
burden per
response
Total annual
responses
Total hours
5 ...........
6 ...........
1 There
5
1
3
13
1
2
65
1
6
10 ................
4 ..................
4 ..................
650
4
24
1
1
1
4 ..................
4
4
9
36
20 ................
720
1
34
34
12 ................
408
4
9
36
18
New Infant Formula Submission; § 106.120 .......
4
9
36
0.50 (30 minutes).
10 ................
360
Total ..............................................................
4 ...........
sradovich on DSK3GMQ082PROD with NOTICES
Number of
responses per
respondent
Number of
respondents
Row No.
........................
........................
........................
.....................
2,188
are no capital costs or operating and maintenance costs associated with this collection of information.
VerDate Sep<11>2014
19:58 Nov 14, 2017
Jkt 244001
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
E:\FR\FM\15NON1.SGM
15NON1
Federal Register / Vol. 82, No. 219 / Wednesday, November 15, 2017 / Notices
In compiling these estimates, we
consulted our records of the number of
infant formula submissions received in
the past. All infant formula submissions
may be provided to us in electronic
format. The hours per response
reporting estimates are based on our
experience with similar programs and
information received from industry.
We estimate that we will receive 13
reports from 5 manufacturers annually
under section 412(d) of the FD&C Act,
for a total annual response of 65 reports.
Each report is estimated to take 10 hours
per response for a total of 650 hours. We
also estimate that we receive one
notification under § 106.120(b). The
notification is expected to take 4 hours
per response, for a total of 4 hours.
For exempt infant formula, we
estimate that we receive two reports
from three manufacturers annually
under § 107.50(b)(3) and (4), for a total
annual response of six reports. Each
report is estimated to take 4 hours per
response for a total of 24 hours. We also
estimate that we receive one notification
annually under § 107.50(e)(2) and that
the notification takes 4 hours to prepare.
We estimate that 4 firms submit 36
exemptions annually and that each
exemption will take 20 hours to
assemble. Therefore, we calculate 36
exemptions × 20 hours = 720 hours as
the estimated burden for § 106.96(c), as
presented in row 5 of table 1.
We estimate that the infant formula
industry annually submits 35 Protein
Efficiency Ratio (PER) submissions. For
the submission of the PER exemption,
we estimate that the infant formula
industry submits 34 exemptions per
year and that each exemption takes
supporting staff 12 hours to prepare.
Therefore, we calculate 34 exemptions ×
12 hours per exemption = 408 hours to
fulfill the requirements of § 106.96(g), as
shown in row 6 of table 1.
We estimate that four firms each use
one senior scientist or regulatory affairs
professional who needs 30 minutes to
gather and record the required
information for an infant formula
registration pursuant to § 106.110. We
estimate that the industry annually
registers 35 new infant formulas, or an
average of 9 registrations per firm.
Therefore, we calculate the annual
burden as 36 registrations × 0.5 hour per
52929
registration = 17.5 (rounded to 18)
hours, as shown in row 7 of table 1.
We estimate that four firms each use
one senior scientist or regulatory affairs
professional who needs 10 hours to
gather and record information needed
for infant formula submissions pursuant
to § 106.120. This estimate includes the
time needed to gather and record the
information the manufacturer uses to
request an exemption under
§ 106.91(b)(1)(ii), which provides that
the manufacturer includes the scientific
evidence that the manufacturer is
relying on to demonstrate that the
stability of the new infant formula will
likely not differ from the stability of
formula with similar composition,
processing, and packaging for which
there are extensive stability data. We
estimate that 4 firms make submissions
for 36 new infant formulas, or an
average of 9 submissions per firm.
Therefore, to comply with § 106.120, we
calculate the annual burden as 36
submissions × 10 hours per submission
= 360 hours, as shown in row 8 of table
1. Thus, the total annual reporting
burden is 2,188 hours.
TABLE 2—ESTIMATED ANNUAL RECORDKEEPING BURDEN 1 2
Row No.
Activity; 21 CFR section
1 ...........
Controls to prevent adulteration caused by facilities—
testing for radiological contaminants 3; § 106.20(f)(3).
Controls to prevent adulteration caused by facilities—
recordkeeping of testing for
radiological contaminants2;
§§ 106.20(f)(4) and
106.100(f)(1).
Controls to prevent adulteration caused by facilities—
testing for bacteriological
contaminants § 106.20(f)(3).
Controls to prevent adulteration caused by facilities—
recordkeeping of testing for
bacteriological contaminants
§§ 106.20(f)(4) and
106.100(f).
Controls to prevent adulteration by equipment or utensils; §§ 106.30(d) and
106.100(f)(2).
Controls to prevent adulteration by equipment or utensils; §§ 106.30(e)(3)(iii) and
106.100(f)(3).
Controls to prevent adulteration by equipment or utensils; §§ 106.30(f) and
106.100(f)(4).
2 ...........
3 ...........
4 ...........
5 ...........
6 ...........
sradovich on DSK3GMQ082PROD with NOTICES
Number of
recordkeepers
7 ...........
VerDate Sep<11>2014
19:58 Nov 14, 2017
Jkt 244001
Number of
records per
recordkeeper
Total annual
records
Average burden per recordkeeping
Total hours
21
21
1.5 (90 minutes) ......................
32
21
1
21
0.08 (5 minutes) ......................
2
5
52
260
0.08 (5 minutes) ......................
21
5
52
260
0.08 (5 minutes) ......................
21
5
52
260
0.22 (13 minutes) ....................
57
5
52
260
0.22 (13 minutes) ....................
57
5
PO 00000
1
52
260
0.20 (12 minutes) ....................
52
Frm 00057
Fmt 4703
Sfmt 4703
E:\FR\FM\15NON1.SGM
15NON1
52930
Federal Register / Vol. 82, No. 219 / Wednesday, November 15, 2017 / Notices
TABLE 2—ESTIMATED ANNUAL RECORDKEEPING BURDEN 1 2—Continued
Row No.
Activity; 21 CFR section
8 ...........
Controls to prevent adulteration due to automatic (mechanical or electronic)
equipment; §§ 106.35(c) and
106.100(f)(5).
Controls to prevent adulteration due to automatic (mechanical or electronic)
equipment §§ 106.35(c) and
106.100(f)(5).
Controls to prevent adulteration caused by ingredients,
containers, and closures;
§§ 106.40(d) and
106.100(f)(6).
Controls to prevent adulteration during manufacturing;
§§ 106.50(a)(1) and
106.100(e).
Controls to prevent adulteration from microorganisms;
§§ 106.55(d) and
106.100(e)(5)(ii) and (f)(7).
Controls to prevent adulteration during packaging and
labeling of infant formula;
§ 106.60(c).
General quality control—testing; § 106.91(b)(1), (2), and
(3).
General quality control;
§§ 106.91(b)(1) and(d), and
106.100(e)(5)(i).
General quality control;
§§ 106.91(b)(2) and (d), and
106.100(e)(5)(i).
General quality control;
§§ 106.91(b)(3) and (d), and
106.100(e)(5)(i).
Audit plans and procedures;
ongoing review and updating of audits; § 106.94.
Audit plans and procedures
—regular audits; § 106.94.
Requirements for quality factors for infant formulas—
written study report;
§§ 106.96(b) and (d),
106.100(p)(1) and (q)(1),
and 106.121.
Requirements for quality factors for infant formulas—anthropometric data;
§§ 106.96(b)(2) and (d), and
106.100(p)(1).
Requirements for quality factors for infant formulas—formula intake §§ 106.96(b)(3)
and (d), and 106.100(p)(1).
Requirements for quality factors for infant formulas—
data plotting; §§ 106.96(b)(4)
and (d), and 106.100(p)(1).
Requirements for quality factors for infant formulas—
data comparison;
§§ 106.96(b)(5) and (d), and
106.100(p)(1).
9 ...........
10 .........
11 .........
12 .........
13 .........
14 .........
15 .........
16 .........
17 .........
18 .........
19 .........
20 .........
21 .........
22 .........
sradovich on DSK3GMQ082PROD with NOTICES
Number of
recordkeepers
23 .........
24 .........
VerDate Sep<11>2014
19:58 Nov 14, 2017
Jkt 244001
Number of
records per
recordkeeper
Total annual
records
Average burden per recordkeeping
Total hours
5
5
520 ..........................................
2,600
5
2
10
640 ..........................................
6,400
5
52
260
0.17 (10 minutes) ....................
44
5
52
260
0.23 (14 minutes) ....................
60
5
52
260
0.25 (15 minutes) ....................
65
1
12
12
0.25 (15 minutes) ....................
3
4
1
4
2 ..............................................
8
4
52
208
0.15 (9 minutes) ......................
31
4
52
208
0.15 (9 minutes) ......................
31
4
52
208
0.15 (9 minutes) ......................
31
5
1
5
8 ..............................................
40
5
52
260
4 ..............................................
1,040
1
1
1
16 ............................................
16
112
6
672
0.50 (30 minutes) ....................
336
112
6
672
0.25 (15 minutes) ....................
168
112
6
672
0.08 (5 minutes) ......................
54
112
PO 00000
1
6
672
0.08 (5 minutes) ......................
54
Frm 00058
Fmt 4703
Sfmt 4703
E:\FR\FM\15NON1.SGM
15NON1
Federal Register / Vol. 82, No. 219 / Wednesday, November 15, 2017 / Notices
52931
TABLE 2—ESTIMATED ANNUAL RECORDKEEPING BURDEN 1 2—Continued
Row No.
Activity; 21 CFR section
25 .........
Requirements for quality factors—per data collection;
§ 106.96(f).
Requirements for quality factors—per written report;
§ 106.96(f).
Records; § 106.100 .................
Records for Exempt Infant
Formula; § 107.50(c)(3).
26 .........
27 .........
28 .........
Total .................................
Number of
records per
recordkeeper
Number of
recordkeepers
Total annual
records
Average burden per recordkeeping
Total hours
1
1
1
8 ..............................................
8
1
1
1
1 ..............................................
1
5
3
10
10
50
30
400 ..........................................
300 ..........................................
20,000
9,000
........................
........................
........................
..................................................
40,232
1 There
are no capital costs or operating and maintenance costs associated with this collection of information.
necessary, numbers have been rounded to the nearest whole number.
testing only occurs every 4 years.
2 Where
sradovich on DSK3GMQ082PROD with NOTICES
3 This
We estimate that 21 infant formula
plants will test at least every 4 years for
radiological contaminants. In addition,
we estimate that collecting water for all
testing in § 106.20(f)(3) takes between 1
and 2 hours. We estimate that water
collection takes an average of 1.5 hours
and that water collection occurs
separately for each type of testing. We
estimate that performing the test will
take 1.5 hours per test, every 4 years.
Therefore, 1.5 hours per plant × 21
plants = 31.5 (rounded to 32) total
hours, every 4 years, as seen in row 1
of table 2. Furthermore, §§ 106.20(f)(4)
and 106.100(f)(1) require firms to make
and retain records of the frequency and
results of water testing. For the 21
plants that are estimated not to
currently test for radiological
contaminants, this burden is estimated
to be 5 minutes per record every 4 years.
Therefore, 0.08 hour per record × 21
plants = 1.68 (rounded to 2) hours,
every 4 years for the maintenance of
records of radiological testing, as seen
on row 2 of table 2.
We estimate that five infant formula
plants will test weekly for
bacteriological contaminants. We
estimate that performing the test will
take 5 minutes per test once a week.
Annually, this burden is 0.08 hours × 52
weeks = 4.16 hours per year, per plant,
and 4.16 hours per plant × 5 plants =
20.8 (rounded to 21) total annual hours,
as seen on row 3 of table 2.
Furthermore, for the five plants that are
estimated to not currently test weekly
for bacteriological contaminants, this
burden is estimated to be 5 minutes per
record, every week. Therefore, 0.08 hour
per record × 52 weeks = 4.16 hours per
plant for the maintenance of records of
bacteriological testing. Accordingly,
4.16 hours × 5 plants = 20.8 (rounded
to 21) annual hours, as seen on row 4
of table 2.
VerDate Sep<11>2014
19:58 Nov 14, 2017
Jkt 244001
Sections 106.30(d) and 106.100(f)(2)
require that records of calibrating
certain instruments be made and
retained. We estimate that one senior
validation engineer for each of the five
plants will need to spend about 13
minutes per week to satisfy the ongoing
calibration recordkeeping requirements.
Therefore, 5 recordkeepers × 52 weeks
= 260 records; 260 records × 0.22 hour
per record = 57 hours as the annual
burden, as presented in row 5 of table
2.
Sections 106.30(e)(3)(iii) and
106.100(f)(3)) require the recordkeeping
of the temperatures of each cold storage
compartment. We estimate that five
plants will each require one senior
validation engineer about 13 minutes
per week of recordkeeping. Therefore, 5
recordkeepers × 52 weeks = 260 records;
260 records × 0.22 hours per record = 57
hours as the annual burden, as
presented in row 6 of table 2.
Sections 106.30(f) and 106.100(f)(4)
require the recordkeeping of ongoing
sanitation efforts. We estimate that five
plants will each require one senior
validation engineer about 12 minutes
per week of recordkeeping. Therefore, 5
recordkeepers × 52 weeks = 260 records;
260 records × 0.20 hours per record = 52
hours as the annual burden, as
presented in row 7 of table 2.
For §§ 106.35(c) and 106.100(f)(5), we
estimate that one senior validation
engineer per plant needs 10 hours per
week of recordkeeping, with the annual
burden for this provision being 520
hours per plant × 5 plants = 2,600
annual hours, as shown in row 8 of table
2. In addition, an infant formula
manufacturer revalidates its systems
when it makes changes to automatic
equipment. We estimate that such
changes occur twice a year, and that on
each of the two occasions, a team of four
senior validation engineers per plant
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
needs to work full time for 4 weeks (4
weeks × 40 hours per week = 160 work
hours per person) to provide
revalidation of the plant’s automated
systems sufficient to comply with this
section. The annual burden for four
senior validation engineers each
working 160 hours twice a year is 1,280
hours ((160 hours × 2 revalidations) × 4
engineers = 1,280 total work hours) per
plant. Therefore, 640 hours × 5 plants ×
2 times per year = 6,400 hours as the
annual burden, as shown on row 9 of
table 2.
Sections 106.40(d) and 106.100(f)(6)
require written specifications for
ingredients, containers, and closures.
We estimate that one senior validation
engineer per plant needs about 10
minutes a week to fulfill the
recordkeeping requirements. Therefore,
5 recordkeepers × 52 weeks = 260
records and 260 records × 0.17 hour =
44 hours as the annual burden, as
shown in row 10 of table 2.
We estimate that five plants will
change a master manufacturing order
and that one senior validation engineer
for each of the five plants spends about
14 minutes per week on recordkeeping
pertaining to the master manufacturing
order, as required by §§ 106.50(a)(1) and
106.100(e). Thus, 5 recordkeepers × 52
weeks = 260 records; 260 records × 0.23
hour = 60 hours as the annual burden,
as shown in row 11 of table 2.
Sections 106.55(d), 106.100(e)(5)(ii),
and 106.100(f)(7)) require recordkeeping
of the testing of infant formula for
microorganisms. We estimate that five
plants each need one senior validation
engineer to spend 15 minutes per week
on recordkeeping pertaining to
microbiological testing. Thus, 5
recordkeepers × 52 weeks = 260 records;
260 records × 0.25 hour per record = 65
hours as the annual burden, as shown
in row 12 of table 2.
E:\FR\FM\15NON1.SGM
15NON1
sradovich on DSK3GMQ082PROD with NOTICES
52932
Federal Register / Vol. 82, No. 219 / Wednesday, November 15, 2017 / Notices
Section 106.60 establishes
requirements for the recordkeeping and
labeling of mixed-lot packages of infant
formula. Section 106.60(c) requires
infant formula diverters to label infant
formula packaging (such as packing
cases) to facilitate product tracing and to
keep specific records of the distribution
of these mixed lot cases. We estimate
that one worker needs 15 minutes, once
a month (0.25 × 12 months) to
accomplish this, for an annual burden of
3 hours, as shown in row 13 of table 2.
Sections 106.91(b)(1), (2), and (3)
provide ongoing stability testing
requirements. We estimate that the
stability testing requirements has a
burden of 2 hours per plant. Therefore,
2 hours × 4 plants = 8 hours as the
annual burden to fulfill the testing
requirements, as shown in row 14 of
table 2.
Sections 106.91(d) and
106.100(e)(5)(i) provide for
recordkeeping of tests required under
§ 106.91(b)(1), (2), and (3). We estimate
that one senior validation engineer per
plant will spend about 9 minutes per
week of recordkeeping to be in
compliance. Thus, 4 recordkeepers × 52
weeks = 208 records; 208 records × 0.15
hour per record = 31.2 (rounded to 31)
hours for the annual burden, as shown
in rows 15, 16, and 17 of table 2.
We estimate that the ongoing review
and updating of audit plans requires a
senior validation engineer 8 hours per
year, per plant. Therefore, 8 hours × 5
plants = 40 hours for the annual burden,
as shown in row 18 of table 2.
We estimate that a manufacturer
chooses to audit once per week. We
estimate each weekly audit requires a
senior validation engineer 4 hours, or 52
weeks × 4 hours = 208 hours per plant.
Therefore, burden for updating audit
plans is calculated as 208 hours × 5
plants = 1,040 hours for the annual
burden, as shown in row 19 of table 2.
We estimate that, as a result of the
regulations, the industry as a whole
performs one additional growth study
per year, in accordance with § 106.96.
The regulations require that several
pieces of data be collected and
maintained for each infant in the growth
study. We estimate that the data
collection associated with the growth
study is assembled into a written report
and kept as a record in compliance with
§§ 106.96(d) and 106.100(p)(1). Thus,
we estimate that one additional growth
study report is generated, and that this
report requires one senior scientist to
work 16 hours to compile the data into
a study report. Therefore, one growth
study report × 16 hours = 16 hours for
the annual burden for compliance with
VerDate Sep<11>2014
19:58 Nov 14, 2017
Jkt 244001
§§ 106.96(b) and (d), 106.100(p)(1) and
(q)(1), and 106.121 as shown in row 20
of table 2.
A study conducted according to the
requirements of § 106.96(b)(2) must
include the collection of anthropometric
measurements of physical growth and
information on formula intake, and
§§ 106.96(d) and 106.100(p)(1) require
that the anthropometric measurements
be made six times during the growth
study. We estimate that in a growth
study of 112 infants, 2 nurses or other
health professionals with similar
experience need 15 minutes per infant
at each of the required 6 times to collect
and record the required anthropometric
measurements. Therefore, 2 nurses ×
0.25 hours = 0.50 hour per infant, per
visit, and 0.50 hour × 6 visits = 3 hours
per infant. For 112 infants in the study,
3 hours × 112 infants = 336 hours for the
annual burden, as shown in row 21 of
table 2. In addition, we estimate that
one nurse needs 15 minutes per infant
to collect and record the formula intake
information. That is, 0.25 hour × 6 visits
= 1.5 hour per infant, and 1.5 hour per
infant × 112 infants = 168 hours for the
annual burden, as shown in row 22 of
table 2.
Section 106.96(b)(4) requires plotting
each infant’s anthropometric
measurements on the Centers for
Disease Control-recommended World
Health Organization Child Growth
Standards. We estimate that it takes 5
minutes per infant to record the
anthropometric data on the growth chart
at each study visit. Therefore, 112
infants × 6 data plots = 672 data plots,
and 672 data plots × 0.08 hour per
comparison = 53.75 hours (rounded to
54) for the annual burden, as shown in
row 23 of table 2.
Section 106.96(b)(5) requires that data
on formula intake by the test group be
compared to the intake of a concurrent
control group. We estimate that one
nurse or other health care professional
with similar experience needs 5 minutes
per infant for each of the six times
anthropometric data are collected.
Therefore, 6 comparisons of data × 112
infants = 672 data comparisons and 672
data comparisons × 0.08 hour per
comparison = 53.75 hours (rounded to
54) for the annual burden, as shown in
row 24 of table 2.
Section 106.96(f) provides that a
manufacturer meets the quality factor of
sufficient biological quality of the
protein by establishing the biological
quality of the protein in the infant
formula when fed as the sole source of
nutrition using an appropriate
modification of the PER rat bioassay.
Under § 106.96(g)(1), a manufacturer of
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
infant formula may be exempt from this
requirement if the manufacturer
requests an exemption and provides
assurances, as required under § 106.121,
that changes made by the manufacturer
to an existing infant formula are limited
to changing the type of packaging. A
manufacturer may also be exempt from
this requirement under § 106.100(g)(2),
if the manufacturer requests an
exemption and provides assurances, as
required under § 106.121, that
demonstrate to FDA’s satisfaction that
the change to an existing formula does
not affect the bioavailability of the
protein. Finally, a manufacturer of
infant formula may be exempt from this
requirement under § 106.96(g)(3) if the
manufacturer requests an exemption
and provides assurances, as required
under § 106.121(i), that demonstrate that
an alternative method to the PER that is
based on sound scientific principles is
available to show that the formula
supports the quality factor for the
biological quality of the protein. We
estimate that the infant formula industry
submits a total of 35 PER submissions:
34 exemption requests and the results of
1 PER study.
A PER study conducted according to
the Association of Analytical
Communities Official Method 960.48 is
28 days in duration. We estimate that
there will be 10 rats in the control and
test groups (20 rats total) and that food
consumption and body weight will be
measured at day 0 and at 7-day intervals
during the 28-day study period (a total
of 5 records per rat). We further estimate
that measuring and recording food
consumption and body weight will take
5 minutes per rat. Therefore, 20 rats ×
5 records = 100 records; 100 records ×
0.08 hour minutes per record = 8 hours
to fulfill the requirements of § 106.96(f).
Further, we estimate that a report based
on the PER study will be generated and
that this study report will take a senior
scientist 1 hour to generate. Therefore,
a total of 9 hours will be required to
fulfill the requirements for § 106.96(f): 8
hours for the PER study and data
collection, and 1 hour for the
development of a report based on the
PER study, as shown in rows 25 and 26
of table 2.
We estimate that five firms will
expend approximately 20,000 hours per
year to fully satisfy the recordkeeping
requirements in § 106.100 and that three
firms will expend approximately 9,000
hours per year to fully satisfy the
recordkeeping requirements in
§ 107.50(c)(3). Thus, the total
recordkeeping burden is 40,232 hours.
E:\FR\FM\15NON1.SGM
15NON1
52933
Federal Register / Vol. 82, No. 219 / Wednesday, November 15, 2017 / Notices
TABLE 3—ESTIMATED ANNUAL THIRD-PARTY DISCLOSURE BURDEN 1
Nutrient labeling; 21 CFR 107.10(a) and 107.20 ................
1 There
Dated: November 8, 2017.
Anna K. Abram,
Deputy Commissioner for Policy, Planning,
Legislation, and Analysis.
[FR Doc. 2017–24688 Filed 11–14–17; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meetings Announcement for the
Physician-Focused Payment Model
Technical Advisory Committee
Required by the Medicare Access and
CHIP Reauthorization Act of 2015
(MACRA)
Notice of public meetings.
This notice announces the
next meeting of the Physician-Focused
Payment Model Technical Advisory
Committee (hereafter referred to as ‘‘the
Committee’’) which will be held in
Washington, DC. This meeting will
include voting and deliberations on
proposals for physician-focused
payment models (PFPMs) submitted by
members of the public. All meetings are
open to the public.
SUMMARY:
The PTAC meeting will occur on
the following dates:
• Monday–Wednesday, December
18–20, 2017, from 9:00 a.m. to 5:00 p.m.
ET.
Please note that times are subject to
change. If the times change, registrants
will be notified directly via email.
DATES:
The December 18–20, 2017
meeting will be held at the Hubert H.
Humphrey Building, 200 Independence
Avenue SW., Washington, DC 20201.
ADDRESSES:
sradovich on DSK3GMQ082PROD with NOTICES
5
Total annual
disclosures
13
Average
burden per
disclosure
65
Total hours
8
520
are no capital costs or operating and maintenance costs associated with this collection of information.
We estimate compliance with our
labeling requirements in §§ 107.10(a)
and 107.20 requires 520 hours annually
by five manufacturers.
ACTION:
Number of
disclosures
per
respondent
Number of
respondents
21 CFR section
Ann
Page, Designated Federal Official, at the
Office of Health Policy, Assistant
Secretary for Planning and Evaluation,
U.S. Department of Health and Human
Services, 200 Independence Ave. SW.,
Washington, DC 20201, (202) 690–6870.
FOR FURTHER INFORMATION CONTACT:
SUPPLEMENTARY INFORMATION:
VerDate Sep<11>2014
19:58 Nov 14, 2017
Jkt 244001
I. Purpose
The Physician-Focused Payment
Model Technical Advisory Committee
(‘‘the Committee’’) is required by the
Medicare Access and CHIP
Reauthorization Act of 2015, 42 U.S.C.
1395ee. This Committee is also
governed by provisions of the Federal
Advisory Committee Act, as amended (5
U.S.C. App.), which sets forth standards
for the formation and use of federal
advisory committees. In accordance
with its statutory mandate, the
Committee is to review physicianfocused payment model proposals and
prepare recommendations regarding
whether such models meet criteria that
were established through rulemaking by
the Secretary of Health and Human
Services (the Secretary). The Committee
is composed of 11 members appointed
by the Comptroller General.
II. Agenda
At the December 18–20, 2017
meeting, the Committee will hear
presentations on PFPMs that are ready
for Committee deliberation. The
presentations will be followed by public
comment and Committee deliberation. If
the Committee completes deliberations,
voting will occur on recommendations
to the Secretary of Health and Human
Services. There will be time allocated
for public comment on agenda items.
Documents will be posted on the
Committee Web site and distributed on
the Committee listserv prior to the
public meeting. The agenda is subject to
change. If the agenda does change, we
will inform registrants and update our
Web site to reflect any changes.
III. Meeting Attendance
The meeting is open to the public.
The public may also attend via
conference call or view the meeting via
livestream at www.hhs.gov/live. The
conference call dial-in information will
be sent to registrants prior to the
meeting.
Registration may be completed online at
www.regonline.com/
PTACMeetingsRegistration.
The following information is
submitted when registering:
Name:
Company/organization name:
Postal address:
Email address:
Persons wishing to attend this
meeting must register by following the
instructions in the ‘‘Meeting
Registration’’ section of this notice. A
confirmation email will be sent to
registrants shortly after completing the
registration process.
IV. Special Accommodations
If sign language interpretation or other
reasonable accommodation for a
disability is needed, please contact
Angela Tejeda, no later than December
4, 2017. Please submit your requests by
email to Angela.Tejeda@hhs.gov or by
calling 202–401–8297.
V. Copies of the PTAC Charter and
Meeting Material
The Secretary’s Charter for the
Physician-Focused Payment Model
Technical Advisory Committee is
available on the ASPE Web site at
https://aspe.hhs.gov/charter-physicianfocused-payment-model-technicaladvisory-committee.
Additional material for this meeting
can be found on the PTAC Web site. For
updates and announcements, please use
the link to subscribe to the PTAC email
listserv.
Dated: September 12, 2017.
John R. Graham,
Acting Assistant Secretary for Planning and
Evaluation.
[FR Doc. 2017–24719 Filed 11–14–17; 8:45 am]
BILLING CODE 4150–05–P
Meeting Registration
The public may attend the meetings
in-person or participate by phone via
audio teleconference. Space is limited
and registration is preferred in order to
attend in-person or by phone.
PO 00000
Frm 00061
Fmt 4703
Sfmt 9990
E:\FR\FM\15NON1.SGM
15NON1
Agencies
[Federal Register Volume 82, Number 219 (Wednesday, November 15, 2017)]
[Notices]
[Pages 52927-52933]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-24688]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2013-N-0545]
Agency Information Collection Activities; Proposed Collection;
Comment Request; Infant Formula Requirements
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA or we) is announcing an
opportunity for public comment on the proposed collection of certain
information by the Agency. Under the Paperwork Reduction Act of 1995
(PRA), Federal Agencies are required to publish notice in the Federal
Register concerning each proposed collection of information, including
each proposed extension of an existing collection of information, and
to allow 60 days for public comment in response to the notice. This
notice invites comments on the information collection provisions of our
infant formula regulations, including infant formula labeling, quality
control procedures, notification requirements, and recordkeeping. The
notice also invites comment on a pilot electronic form that allows
manufacturers of infant formula to submit reports and notifications in
a standardized format.
DATES: Submit either electronic or written comments on the collection
of information by January 16, 2018.
ADDRESSES: You may submit comments as follows. Please note that late,
untimely filed comments will not be considered. Electronic comments
must be submitted on or before January 16, 2018. The https://www.regulations.gov electronic filing system will accept comments until
midnight Eastern Time at the end of January 16, 2018. Comments received
by mail/hand delivery/courier (for written/paper submissions) will be
considered timely if they are postmarked or the delivery service
acceptance receipt is on or before that date.
Electronic Submissions
Submit electronic comments in the following way:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to https://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on https://www.regulations.gov.
If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').
Written/Paper Submissions
Submit written/paper submissions as follows:
Mail/Hand delivery/Courier (for written/paper
submissions): Dockets Management Staff (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
For written/paper comments submitted to the Dockets
Management Staff, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
Instructions: All submissions received must include the Docket No.
FDA-2013-N-0545 for ``Agency Information Collection Activities;
Proposed Collection; Comment Request; Infant Formula Requirements.''
Received comments, those filed in a timely manner (see ADDRESSES), will
be placed in the docket and, except for those submitted as
``Confidential Submissions,'' publicly viewable at https://www.regulations.gov or at the Dockets Management Staff between 9 a.m.
and 4 p.m., Monday through Friday.
Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will
review this copy, including the claimed confidential information, in
its consideration of comments. The second copy, which will have the
claimed confidential information redacted/blacked out, will be
available for public viewing and posted on
[[Page 52928]]
https://www.regulations.gov. Submit both copies to the Dockets
Management Staff. If you do not wish your name and contact information
to be made publicly available, you can provide this information on the
cover sheet and not in the body of your comments and you must identify
this information as ``confidential.'' Any information marked as
``confidential'' will not be disclosed except in accordance with 21 CFR
10.20 and other applicable disclosure law. For more information about
FDA's posting of comments to public dockets, see 80 FR 56469, September
18, 2015, or access the information at: https://www.gpo.gov/fdsys/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Operations,
Food and Drug Administration, Three White Flint North, 10A-12M, 11601
Landsdown St., North Bethesda, MD 20852, 301-796-7726,
PRAStaff@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501-3520), Federal
Agencies must obtain approval from the Office of Management and Budget
(OMB) for each collection of information they conduct or sponsor.
``Collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A))
requires Federal Agencies to provide a 60-day notice in the Federal
Register concerning each proposed collection of information, including
each proposed extension of an existing collection of information,
before submitting the collection to OMB for approval. To comply with
this requirement, FDA is publishing notice of the proposed collection
of information set forth in this document.
With respect to the following collection of information, we invite
comments on these topics: (1) Whether the proposed collection of
information is necessary for the proper performance of FDA's functions,
including whether the information will have practical utility; (2) the
accuracy of FDA's estimate of the burden of the proposed collection of
information, including the validity of the methodology and assumptions
used; (3) ways to enhance the quality, utility, and clarity of the
information to be collected; and (4) ways to minimize the burden of the
collection of information on respondents, including through the use of
automated collection techniques, when appropriate, and other forms of
information technology.
Infant Formula Requirements--21 CFR parts 106 and 107
OMB Control Number 0910-0256--Extension
Statutory requirements for infant formula under the Federal Food,
Drug, and Cosmetic Act (the FD&C Act) are intended to protect the
health of infants and include a number of reporting and recordkeeping
requirements. Among other things, section 412 of the FD&C Act (21
U.S.C. 350a) requires manufacturers of infant formula to establish and
adhere to quality control procedures, notify us when a batch of infant
formula that has left the manufacturers' control may be adulterated or
misbranded, and keep records of distribution. We have issued
regulations to implement the FD&C Act's requirements for infant formula
in parts 106 and 107 (21 CFR parts 106 and 107). We also regulate the
labeling of infant formula under the authority of section 403 of the
FD&C Act (21 U.S.C. 343). Under our labeling regulations for infant
formula in part 107, the label of an infant formula must include
nutrient information and directions for use. The purpose of these
labeling requirements is to ensure that consumers have the information
they need to prepare and use infant formula appropriately.
We have developed an electronic form (Form FDA 3978) that infant
formula manufacturers will be able to use to electronically submit
reports and notifications in a standardized format to FDA.
Manufacturers that prefer to submit paper submissions in a format of
their own choosing will still have the option to do so, however. Form
FDA 3978 prompts a respondent to include reports and notifications in a
standard electronic format and helps the respondent organize their
submission to include only the information needed for our review. Draft
screenshots of Form FDA 3978 and instructions are available for comment
at https://www.fda.gov/Food/GuidanceRegulation/FoodFacilityRegistration/InfantFormula/default.htm.
Description of Respondents: Respondents to this information
collection are manufacturers of infant formula.
We estimate the burden of this collection of information as
follows:
Table 1--Estimated Annual Reporting Burden \1\
----------------------------------------------------------------------------------------------------------------
Number of
Row No. FD&C Act or 21 Number of responses per Total annual Average burden Total hours
CFR section respondents respondent responses per response
----------------------------------------------------------------------------------------------------------------
1.......... Reports; Section 5 13 65 10............... 650
412(d) of the
FD&C Act.
2.......... Notifications; 1 1 1 4................ 4
Sec.
106.120(b).
3.......... Reports for 3 2 6 4................ 24
Exempt Infant
Formula; Sec.
107.50(b)(3)
and (4).
4.......... Notifications 1 1 1 4................ 4
for Exempt
Infant
Formula;Sec.
107.50(e)(2).
5.......... Requirements for 4 9 36 20............... 720
Quality Factors
Growth
Monitoring
Study
Exemption; Sec.
106.96(c).
6.......... Requirements for 1 34 34 12............... 408
Quality
Factors--PER
Exemption; Sec.
106.96(g).
7.......... New Infant 4 9 36 0.50 (30 minutes) 18
Formula
Registration;
Sec. 106.110.
8.......... New Infant 4 9 36 10............... 360
Formula
Submission;
Sec. 106.120.
----------------------------------------------------------------------------------
Total........ .............. .............. .............. ................. 2,188
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
information.
[[Page 52929]]
In compiling these estimates, we consulted our records of the
number of infant formula submissions received in the past. All infant
formula submissions may be provided to us in electronic format. The
hours per response reporting estimates are based on our experience with
similar programs and information received from industry.
We estimate that we will receive 13 reports from 5 manufacturers
annually under section 412(d) of the FD&C Act, for a total annual
response of 65 reports. Each report is estimated to take 10 hours per
response for a total of 650 hours. We also estimate that we receive one
notification under Sec. 106.120(b). The notification is expected to
take 4 hours per response, for a total of 4 hours.
For exempt infant formula, we estimate that we receive two reports
from three manufacturers annually under Sec. 107.50(b)(3) and (4), for
a total annual response of six reports. Each report is estimated to
take 4 hours per response for a total of 24 hours. We also estimate
that we receive one notification annually under Sec. 107.50(e)(2) and
that the notification takes 4 hours to prepare.
We estimate that 4 firms submit 36 exemptions annually and that
each exemption will take 20 hours to assemble. Therefore, we calculate
36 exemptions x 20 hours = 720 hours as the estimated burden for Sec.
106.96(c), as presented in row 5 of table 1.
We estimate that the infant formula industry annually submits 35
Protein Efficiency Ratio (PER) submissions. For the submission of the
PER exemption, we estimate that the infant formula industry submits 34
exemptions per year and that each exemption takes supporting staff 12
hours to prepare. Therefore, we calculate 34 exemptions x 12 hours per
exemption = 408 hours to fulfill the requirements of Sec. 106.96(g),
as shown in row 6 of table 1.
We estimate that four firms each use one senior scientist or
regulatory affairs professional who needs 30 minutes to gather and
record the required information for an infant formula registration
pursuant to Sec. 106.110. We estimate that the industry annually
registers 35 new infant formulas, or an average of 9 registrations per
firm. Therefore, we calculate the annual burden as 36 registrations x
0.5 hour per registration = 17.5 (rounded to 18) hours, as shown in row
7 of table 1.
We estimate that four firms each use one senior scientist or
regulatory affairs professional who needs 10 hours to gather and record
information needed for infant formula submissions pursuant to Sec.
106.120. This estimate includes the time needed to gather and record
the information the manufacturer uses to request an exemption under
Sec. 106.91(b)(1)(ii), which provides that the manufacturer includes
the scientific evidence that the manufacturer is relying on to
demonstrate that the stability of the new infant formula will likely
not differ from the stability of formula with similar composition,
processing, and packaging for which there are extensive stability data.
We estimate that 4 firms make submissions for 36 new infant formulas,
or an average of 9 submissions per firm. Therefore, to comply with
Sec. 106.120, we calculate the annual burden as 36 submissions x 10
hours per submission = 360 hours, as shown in row 8 of table 1. Thus,
the total annual reporting burden is 2,188 hours.
Table 2--Estimated Annual Recordkeeping Burden \1\ \2\
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Row No. Activity; 21 CFR Number of records per Total annual per Total hours
section recordkeepers recordkeeper records recordkeeping
----------------------------------------------------------------------------------------------------------------
1........... Controls to 21 1 21 1.5 (90 minutes) 32
prevent
adulteration
caused by
facilities--tes
ting for
radiological
contaminants
\3\; Sec.
106.20(f)(3).
2........... Controls to 21 1 21 0.08 (5 minutes) 2
prevent
adulteration
caused by
facilities--rec
ordkeeping of
testing for
radiological
contaminants\2\
; Sec. Sec.
106.20(f)(4)
and
106.100(f)(1).
3........... Controls to 5 52 260 0.08 (5 minutes) 21
prevent
adulteration
caused by
facilities--tes
ting for
bacteriological
contaminants
Sec.
106.20(f)(3).
4........... Controls to 5 52 260 0.08 (5 minutes) 21
prevent
adulteration
caused by
facilities--rec
ordkeeping of
testing for
bacteriological
contaminants
Sec. Sec.
106.20(f)(4)
and 106.100(f).
5........... Controls to 5 52 260 0.22 (13 57
prevent minutes).
adulteration by
equipment or
utensils; Sec.
Sec.
106.30(d) and
106.100(f)(2).
6........... Controls to 5 52 260 0.22 (13 57
prevent minutes).
adulteration by
equipment or
utensils; Sec.
Sec.
106.30(e)(3)(ii
i) and
106.100(f)(3).
7........... Controls to 5 52 260 0.20 (12 52
prevent minutes).
adulteration by
equipment or
utensils; Sec.
Sec.
106.30(f) and
106.100(f)(4).
[[Page 52930]]
8........... Controls to 5 1 5 520............. 2,600
prevent
adulteration
due to
automatic
(mechanical or
electronic)
equipment; Sec.
Sec.
106.35(c) and
106.100(f)(5).
9........... Controls to 5 2 10 640............. 6,400
prevent
adulteration
due to
automatic
(mechanical or
electronic)
equipment Sec.
Sec.
106.35(c) and
106.100(f)(5).
10.......... Controls to 5 52 260 0.17 (10 44
prevent minutes).
adulteration
caused by
ingredients,
containers, and
closures; Sec.
Sec.
106.40(d) and
106.100(f)(6).
11.......... Controls to 5 52 260 0.23 (14 60
prevent minutes).
adulteration
during
manufacturing;
Sec. Sec.
106.50(a)(1)
and 106.100(e).
12.......... Controls to 5 52 260 0.25 (15 65
prevent minutes).
adulteration
from
microorganisms;
Sec. Sec.
106.55(d) and
106.100(e)(5)(i
i) and (f)(7).
13.......... Controls to 1 12 12 0.25 (15 3
prevent minutes).
adulteration
during
packaging and
labeling of
infant formula;
Sec.
106.60(c).
14.......... General quality 4 1 4 2............... 8
control--testin
g; Sec.
106.91(b)(1),
(2), and (3).
15.......... General quality 4 52 208 0.15 (9 minutes) 31
control; Sec.
Sec.
106.91(b)(1)
and(d), and
106.100(e)(5)(i
).
16.......... General quality 4 52 208 0.15 (9 minutes) 31
control; Sec.
Sec.
106.91(b)(2)
and (d), and
106.100(e)(5)(i
).
17.......... General quality 4 52 208 0.15 (9 minutes) 31
control; Sec.
Sec.
106.91(b)(3)
and (d), and
106.100(e)(5)(i
).
18.......... Audit plans and 5 1 5 8............... 40
procedures;
ongoing review
and updating of
audits; Sec.
106.94.
19.......... Audit plans and 5 52 260 4............... 1,040
procedures --
regular audits;
Sec. 106.94.
20.......... Requirements for 1 1 1 16.............. 16
quality factors
for infant
formulas--writt
en study
report; Sec.
Sec.
106.96(b) and
(d),
106.100(p)(1)
and (q)(1), and
106.121.
21.......... Requirements for 112 6 672 0.50 (30 336
quality factors minutes).
for infant
formulas--anthr
opometric data;
Sec. Sec.
106.96(b)(2)
and (d), and
106.100(p)(1).
22.......... Requirements for 112 6 672 0.25 (15 168
quality factors minutes).
for infant
formulas--formu
la intake Sec.
Sec.
106.96(b)(3)
and (d), and
106.100(p)(1).
23.......... Requirements for 112 6 672 0.08 (5 minutes) 54
quality factors
for infant
formulas--data
plotting; Sec.
Sec.
106.96(b)(4)
and (d), and
106.100(p)(1).
24.......... Requirements for 112 6 672 0.08 (5 minutes) 54
quality factors
for infant
formulas--data
comparison;
Sec. Sec.
106.96(b)(5)
and (d), and
106.100(p)(1).
[[Page 52931]]
25.......... Requirements for 1 1 1 8............... 8
quality
factors--per
data
collection;
Sec.
106.96(f).
26.......... Requirements for 1 1 1 1............... 1
quality
factors--per
written report;
Sec.
106.96(f).
27.......... Records; Sec. 5 10 50 400............. 20,000
106.100.
28.......... Records for 3 10 30 300............. 9,000
Exempt Infant
Formula; Sec.
107.50(c)(3).
---------------------------------------------------------------------------------
Total........ .............. .............. .............. ................ 40,232
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
information.
\2\ Where necessary, numbers have been rounded to the nearest whole number.
\3\ This testing only occurs every 4 years.
We estimate that 21 infant formula plants will test at least every
4 years for radiological contaminants. In addition, we estimate that
collecting water for all testing in Sec. 106.20(f)(3) takes between 1
and 2 hours. We estimate that water collection takes an average of 1.5
hours and that water collection occurs separately for each type of
testing. We estimate that performing the test will take 1.5 hours per
test, every 4 years. Therefore, 1.5 hours per plant x 21 plants = 31.5
(rounded to 32) total hours, every 4 years, as seen in row 1 of table
2. Furthermore, Sec. Sec. 106.20(f)(4) and 106.100(f)(1) require firms
to make and retain records of the frequency and results of water
testing. For the 21 plants that are estimated not to currently test for
radiological contaminants, this burden is estimated to be 5 minutes per
record every 4 years. Therefore, 0.08 hour per record x 21 plants =
1.68 (rounded to 2) hours, every 4 years for the maintenance of records
of radiological testing, as seen on row 2 of table 2.
We estimate that five infant formula plants will test weekly for
bacteriological contaminants. We estimate that performing the test will
take 5 minutes per test once a week. Annually, this burden is 0.08
hours x 52 weeks = 4.16 hours per year, per plant, and 4.16 hours per
plant x 5 plants = 20.8 (rounded to 21) total annual hours, as seen on
row 3 of table 2. Furthermore, for the five plants that are estimated
to not currently test weekly for bacteriological contaminants, this
burden is estimated to be 5 minutes per record, every week. Therefore,
0.08 hour per record x 52 weeks = 4.16 hours per plant for the
maintenance of records of bacteriological testing. Accordingly, 4.16
hours x 5 plants = 20.8 (rounded to 21) annual hours, as seen on row 4
of table 2.
Sections 106.30(d) and 106.100(f)(2) require that records of
calibrating certain instruments be made and retained. We estimate that
one senior validation engineer for each of the five plants will need to
spend about 13 minutes per week to satisfy the ongoing calibration
recordkeeping requirements. Therefore, 5 recordkeepers x 52 weeks = 260
records; 260 records x 0.22 hour per record = 57 hours as the annual
burden, as presented in row 5 of table 2.
Sections 106.30(e)(3)(iii) and 106.100(f)(3)) require the
recordkeeping of the temperatures of each cold storage compartment. We
estimate that five plants will each require one senior validation
engineer about 13 minutes per week of recordkeeping. Therefore, 5
recordkeepers x 52 weeks = 260 records; 260 records x 0.22 hours per
record = 57 hours as the annual burden, as presented in row 6 of table
2.
Sections 106.30(f) and 106.100(f)(4) require the recordkeeping of
ongoing sanitation efforts. We estimate that five plants will each
require one senior validation engineer about 12 minutes per week of
recordkeeping. Therefore, 5 recordkeepers x 52 weeks = 260 records; 260
records x 0.20 hours per record = 52 hours as the annual burden, as
presented in row 7 of table 2.
For Sec. Sec. 106.35(c) and 106.100(f)(5), we estimate that one
senior validation engineer per plant needs 10 hours per week of
recordkeeping, with the annual burden for this provision being 520
hours per plant x 5 plants = 2,600 annual hours, as shown in row 8 of
table 2. In addition, an infant formula manufacturer revalidates its
systems when it makes changes to automatic equipment. We estimate that
such changes occur twice a year, and that on each of the two occasions,
a team of four senior validation engineers per plant needs to work full
time for 4 weeks (4 weeks x 40 hours per week = 160 work hours per
person) to provide revalidation of the plant's automated systems
sufficient to comply with this section. The annual burden for four
senior validation engineers each working 160 hours twice a year is
1,280 hours ((160 hours x 2 revalidations) x 4 engineers = 1,280 total
work hours) per plant. Therefore, 640 hours x 5 plants x 2 times per
year = 6,400 hours as the annual burden, as shown on row 9 of table 2.
Sections 106.40(d) and 106.100(f)(6) require written specifications
for ingredients, containers, and closures. We estimate that one senior
validation engineer per plant needs about 10 minutes a week to fulfill
the recordkeeping requirements. Therefore, 5 recordkeepers x 52 weeks =
260 records and 260 records x 0.17 hour = 44 hours as the annual
burden, as shown in row 10 of table 2.
We estimate that five plants will change a master manufacturing
order and that one senior validation engineer for each of the five
plants spends about 14 minutes per week on recordkeeping pertaining to
the master manufacturing order, as required by Sec. Sec. 106.50(a)(1)
and 106.100(e). Thus, 5 recordkeepers x 52 weeks = 260 records; 260
records x 0.23 hour = 60 hours as the annual burden, as shown in row 11
of table 2.
Sections 106.55(d), 106.100(e)(5)(ii), and 106.100(f)(7)) require
recordkeeping of the testing of infant formula for microorganisms. We
estimate that five plants each need one senior validation engineer to
spend 15 minutes per week on recordkeeping pertaining to
microbiological testing. Thus, 5 recordkeepers x 52 weeks = 260
records; 260 records x 0.25 hour per record = 65 hours as the annual
burden, as shown in row 12 of table 2.
[[Page 52932]]
Section 106.60 establishes requirements for the recordkeeping and
labeling of mixed-lot packages of infant formula. Section 106.60(c)
requires infant formula diverters to label infant formula packaging
(such as packing cases) to facilitate product tracing and to keep
specific records of the distribution of these mixed lot cases. We
estimate that one worker needs 15 minutes, once a month (0.25 x 12
months) to accomplish this, for an annual burden of 3 hours, as shown
in row 13 of table 2.
Sections 106.91(b)(1), (2), and (3) provide ongoing stability
testing requirements. We estimate that the stability testing
requirements has a burden of 2 hours per plant. Therefore, 2 hours x 4
plants = 8 hours as the annual burden to fulfill the testing
requirements, as shown in row 14 of table 2.
Sections 106.91(d) and 106.100(e)(5)(i) provide for recordkeeping
of tests required under Sec. 106.91(b)(1), (2), and (3). We estimate
that one senior validation engineer per plant will spend about 9
minutes per week of recordkeeping to be in compliance. Thus, 4
recordkeepers x 52 weeks = 208 records; 208 records x 0.15 hour per
record = 31.2 (rounded to 31) hours for the annual burden, as shown in
rows 15, 16, and 17 of table 2.
We estimate that the ongoing review and updating of audit plans
requires a senior validation engineer 8 hours per year, per plant.
Therefore, 8 hours x 5 plants = 40 hours for the annual burden, as
shown in row 18 of table 2.
We estimate that a manufacturer chooses to audit once per week. We
estimate each weekly audit requires a senior validation engineer 4
hours, or 52 weeks x 4 hours = 208 hours per plant. Therefore, burden
for updating audit plans is calculated as 208 hours x 5 plants = 1,040
hours for the annual burden, as shown in row 19 of table 2.
We estimate that, as a result of the regulations, the industry as a
whole performs one additional growth study per year, in accordance with
Sec. 106.96. The regulations require that several pieces of data be
collected and maintained for each infant in the growth study. We
estimate that the data collection associated with the growth study is
assembled into a written report and kept as a record in compliance with
Sec. Sec. 106.96(d) and 106.100(p)(1). Thus, we estimate that one
additional growth study report is generated, and that this report
requires one senior scientist to work 16 hours to compile the data into
a study report. Therefore, one growth study report x 16 hours = 16
hours for the annual burden for compliance with Sec. Sec. 106.96(b)
and (d), 106.100(p)(1) and (q)(1), and 106.121 as shown in row 20 of
table 2.
A study conducted according to the requirements of Sec.
106.96(b)(2) must include the collection of anthropometric measurements
of physical growth and information on formula intake, and Sec. Sec.
106.96(d) and 106.100(p)(1) require that the anthropometric
measurements be made six times during the growth study. We estimate
that in a growth study of 112 infants, 2 nurses or other health
professionals with similar experience need 15 minutes per infant at
each of the required 6 times to collect and record the required
anthropometric measurements. Therefore, 2 nurses x 0.25 hours = 0.50
hour per infant, per visit, and 0.50 hour x 6 visits = 3 hours per
infant. For 112 infants in the study, 3 hours x 112 infants = 336 hours
for the annual burden, as shown in row 21 of table 2. In addition, we
estimate that one nurse needs 15 minutes per infant to collect and
record the formula intake information. That is, 0.25 hour x 6 visits =
1.5 hour per infant, and 1.5 hour per infant x 112 infants = 168 hours
for the annual burden, as shown in row 22 of table 2.
Section 106.96(b)(4) requires plotting each infant's anthropometric
measurements on the Centers for Disease Control-recommended World
Health Organization Child Growth Standards. We estimate that it takes 5
minutes per infant to record the anthropometric data on the growth
chart at each study visit. Therefore, 112 infants x 6 data plots = 672
data plots, and 672 data plots x 0.08 hour per comparison = 53.75 hours
(rounded to 54) for the annual burden, as shown in row 23 of table 2.
Section 106.96(b)(5) requires that data on formula intake by the
test group be compared to the intake of a concurrent control group. We
estimate that one nurse or other health care professional with similar
experience needs 5 minutes per infant for each of the six times
anthropometric data are collected. Therefore, 6 comparisons of data x
112 infants = 672 data comparisons and 672 data comparisons x 0.08 hour
per comparison = 53.75 hours (rounded to 54) for the annual burden, as
shown in row 24 of table 2.
Section 106.96(f) provides that a manufacturer meets the quality
factor of sufficient biological quality of the protein by establishing
the biological quality of the protein in the infant formula when fed as
the sole source of nutrition using an appropriate modification of the
PER rat bioassay. Under Sec. 106.96(g)(1), a manufacturer of infant
formula may be exempt from this requirement if the manufacturer
requests an exemption and provides assurances, as required under Sec.
106.121, that changes made by the manufacturer to an existing infant
formula are limited to changing the type of packaging. A manufacturer
may also be exempt from this requirement under Sec. 106.100(g)(2), if
the manufacturer requests an exemption and provides assurances, as
required under Sec. 106.121, that demonstrate to FDA's satisfaction
that the change to an existing formula does not affect the
bioavailability of the protein. Finally, a manufacturer of infant
formula may be exempt from this requirement under Sec. 106.96(g)(3) if
the manufacturer requests an exemption and provides assurances, as
required under Sec. 106.121(i), that demonstrate that an alternative
method to the PER that is based on sound scientific principles is
available to show that the formula supports the quality factor for the
biological quality of the protein. We estimate that the infant formula
industry submits a total of 35 PER submissions: 34 exemption requests
and the results of 1 PER study.
A PER study conducted according to the Association of Analytical
Communities Official Method 960.48 is 28 days in duration. We estimate
that there will be 10 rats in the control and test groups (20 rats
total) and that food consumption and body weight will be measured at
day 0 and at 7-day intervals during the 28-day study period (a total of
5 records per rat). We further estimate that measuring and recording
food consumption and body weight will take 5 minutes per rat.
Therefore, 20 rats x 5 records = 100 records; 100 records x 0.08 hour
minutes per record = 8 hours to fulfill the requirements of Sec.
106.96(f). Further, we estimate that a report based on the PER study
will be generated and that this study report will take a senior
scientist 1 hour to generate. Therefore, a total of 9 hours will be
required to fulfill the requirements for Sec. 106.96(f): 8 hours for
the PER study and data collection, and 1 hour for the development of a
report based on the PER study, as shown in rows 25 and 26 of table 2.
We estimate that five firms will expend approximately 20,000 hours
per year to fully satisfy the recordkeeping requirements in Sec.
106.100 and that three firms will expend approximately 9,000 hours per
year to fully satisfy the recordkeeping requirements in Sec.
107.50(c)(3). Thus, the total recordkeeping burden is 40,232 hours.
[[Page 52933]]
Table 3--Estimated Annual Third-Party Disclosure Burden \1\
----------------------------------------------------------------------------------------------------------------
Number of
Number of disclosures Total annual Average burden
21 CFR section respondents per disclosures per disclosure Total hours
respondent
----------------------------------------------------------------------------------------------------------------
Nutrient labeling; 21 CFR 5 13 65 8 520
107.10(a) and 107.20...........
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
information.
We estimate compliance with our labeling requirements in Sec. Sec.
107.10(a) and 107.20 requires 520 hours annually by five manufacturers.
Dated: November 8, 2017.
Anna K. Abram,
Deputy Commissioner for Policy, Planning, Legislation, and Analysis.
[FR Doc. 2017-24688 Filed 11-14-17; 8:45 am]
BILLING CODE 4164-01-P